{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:11:49Z","timestamp":1770509509114,"version":"3.49.0"},"reference-count":17,"publisher":"Informa UK Limited","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.3109\/10428199909145955","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T12:14:55Z","timestamp":1208952895000},"page":"123-128","source":"Crossref","is-referenced-by-count":12,"title":["Long-Term Interferon-Alpha 2A Does not Induce Sustained Hematologic Remission in Younger Patients with Essential Thrombocythemia"],"prefix":"10.1080","volume":"36","author":[{"given":"M.","family":"Bentley","sequence":"first","affiliation":[{"name":"Department of Haematology, Mater Hospital, Brisbane"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Haematology, Mater Hospital, Brisbane"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grigg","sequence":"additional","affiliation":[{"name":"Departrnent of Haematology, Royal Melbourne Hospital, Melbourne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kronenberg","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gibson","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bunce","sequence":"additional","affiliation":[{"name":"Clinics for Haematology and Oncology, Wesley Medical Centre, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Eliadis","sequence":"additional","affiliation":[{"name":"Clinics for Haematology and Oncology, Wesley Medical Centre, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Clinics for Haematology and Oncology, Wesley Medical Centre, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Haematology, Mater Hospital, Brisbane"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Haematology, Mater Hospital, Brisbane"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rodwell","sequence":"additional","affiliation":[{"name":"Department of Haematology, Mater Hospital, Brisbane"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7]]},"reference":[{"key":"e_1_2_1_2_1","article-title":"Even young patients with essential thrornbocythemia are prone to thrombosis","author":"Randi M. L.","year":"1997","unstructured":"Randi M. L., Tossi C., Fabris F., Piccoli A, Rinaldi V., Girolami A. Even young patients with essential thrornbocythemia are prone to thrombosis. Thrombosis and Haemostasis 1997, June (suppl.), PS 184.","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430110137015"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/14767059609025401"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.10.2103.2103"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(97)90001-1"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400931"},{"key":"e_1_2_1_8_1","first-page":"1232","article-title":"Experimental study of transplacental passage of alpha interferon by two assay techniques","volume":"37","author":"Waysbort A.","year":"1993","unstructured":"Waysbort A., Giroux M., Mansat V., Teixeira M., Dumas J. C., Puel J. Experimental study of transplacental passage of alpha interferon by two assay techniques. Journal of Antimicrobials and Chemorherapeutics 1993; 37: 1232\u20131237","journal-title":"Journal of Antimicrobials and Chemorherapeutics"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06447.x"},{"key":"e_1_2_1_10_1","first-page":"70","article-title":"Alpha-Interferon Therapy for Essential Thrombocythaemia (letter)","author":"Giles F.","year":"1998","unstructured":"Giles F., Gray A., Brozovic M., Grant I., Machin S. Alpha-Interferon Therapy for Essential Thrombocythaemia (letter). Lancet 1998; 70\u201372, (July 9)","journal-title":"Lancet"},{"key":"e_1_2_1_11_1","first-page":"32","article-title":"Remission may continue after determination of rIFN\u03b1-2b treatment for essential thrombocythernia","volume":"48","author":"Kasparu H.","year":"1992","unstructured":"Kasparu H., Bernhart M., Krieger O., Lutz D. Remission may continue after determination of rIFN\u03b1-2b treatment for essential thrombocythernia. European Journal of Haemarology 1992; 48: 32\u201336","journal-title":"European Journal of Haemarology"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01738473"},{"key":"e_1_2_1_13_1","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with Essential Thrombocythemia: A Final Report on Diagnostic Criteria. Survival, and Leukemic Transition by Treatment","volume":"34","author":"Murphy S.","year":"1997","unstructured":"Murphy S., Peterson P., Iland H., Laszlo J. Experience of the Polycythemia Vera Study Group with Essential Thrombocythemia: A Final Report on Diagnostic Criteria. Survival, and Leukemic Transition by Treatment. Seminars in Hematology 1997; 34: 29\u201339","journal-title":"Seminars in Hematology"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.3.556"},{"key":"e_1_2_1_15_1","first-page":"126","article-title":"Recombinant Interferon Alpha-2b as Treatment of Essential Thrornbocythaemia","volume":"3","author":"Rametta V.","year":"1991","unstructured":"Rametta V., Ferrara F., Marattoli V., Matera C., Mettivier V., Chino R. Recombinant Interferon Alpha-2b as Treatment of Essential Thrornbocythaemia. Acra Hoematology 1991; 3: 126\u2013129","journal-title":"Acra Hoematology"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03391.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92142-9"},{"key":"e_1_2_1_18_1","first-page":"513","article-title":"Interferons and oncogenes","volume":"313","author":"Clemens M","year":"1986","unstructured":"Clemens M. Interferons and oncogenes. Nature 1986; 313: 513\u2013532","journal-title":"Nature"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428199909145955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:52:11Z","timestamp":1770414731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428199909145955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":17,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.3109\/10428199909145955"],"URL":"https:\/\/doi.org\/10.3109\/10428199909145955","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}